Life-sciences companies are navigating unprecedented yet uncertain times. The collision of scientific progress, technology disruptions, and innovation in clinical practice has tremendous potential to improve patients’ lives and create corporate value. Yet it is not proving easy to realize that potential.Most life-sciences executives agree that long-term value creation lies in innovation-led growth, with digital and analytics at its core. And most companies have made significant investments to harness that value, undertaking projects and pilots that give glimpses of the exciting rewards ahead for stakeholders. But the vision of a digitally transformed life-sciences company in which people, data, technology, and partner organizations work together to create a virtuous cycle of innovation and value creation remains tantalizingly out of reach because it has proven hard to scale projects.Pioneering life-sciences companies are now beginning to discover the solution, however, by...
learn more
